Short-lead-time supply of hard and specialty lenses from manufacturing facilities in China
First written in FY2021-Q1. 3 of 6 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024AdvancedAnnual report
「The company also began producing orthokeratology lenses in China to increase production volumes and shorten lead times.」
Production of orthokeratology lenses began in China, putting in place a local supply structure aimed at increasing production volumes and shortening lead times. - FY2023RestatedAnnual report
「The company strengthened its investment in increased production capacity, including the establishment of a local production structure, to ensure a stable supply of products and further expand future sales of orthokeratology lenses.」
The company continues to establish a local production structure and invest in increased production capacity to prepare for future demand for orthokeratology lenses. - FY2023-Q1RestatedAnnual report
「The company also worked to strengthen its production and supply structure to ensure stable supply and prepare for future demand.」
The company continues to strengthen its production and supply structure for orthokeratology lenses and other products in China to ensure stable supply and prepare for future demand. - FY2022RestatedAnnual report
「To achieve a stable supply of products in preparation for further sales growth, we strengthened investment in production expansion, including the establishment of a local production system.」
The company continues to establish a local production structure and invest in increased production capacity for orthokeratology lenses in China. - FY2021-Q3AdvancedAnnual report
「To meet growing demand, 株式会社アルファコーポレーション, a Group company that manufactures orthokeratology lenses, established a local subsidiary in China with the aim of starting mass production in 2024. These activities have laid the foundation for establishing an integrated manufacturing and sales structure in the Chinese market.」
The establishment of a local subsidiary in China and the plan to begin mass production in 2024 put in place local supply of hard and specialty lenses and an integrated manufacturing and sales structure in China. - FY2021-Q1First statedAnnual report
「In recent years, the number of people with myopia and those seeking treatment for irregular corneal astigmatism has increased in China. Accordingly, the company established a manufacturing base in China to provide hard contact lenses and specialty lenses to local medical institutions and patients with short lead times. Going forward, it will work to further expand its sales base with the support of its technology.」
Against a backdrop of rising demand in China, the company established a local manufacturing base to supply hard contact lenses and specialty lenses with short lead times, positioning it as a means of expanding its sales base.